Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.71)
# 771
Out of 5,090 analysts
83
Total ratings
40.74%
Success rate
11.55%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARCT Arcturus Therapeutics Holdings | Maintains: Overweight | $140 → $72 | $6.78 | +961.95% | 2 | Nov 11, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $15 → $36 | $11.30 | +218.58% | 5 | Oct 28, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Overweight | $400 → $540 | $591.06 | -8.64% | 4 | Oct 15, 2025 | |
| LBRX LB Pharmaceuticals | Initiates: Overweight | $78 | $19.36 | +302.89% | 1 | Oct 6, 2025 | |
| TENX Tenax Therapeutics | Initiates: Overweight | $20 | $9.34 | +114.13% | 1 | Sep 8, 2025 | |
| IVA Inventiva | Initiates: Overweight | $26 | $4.13 | +529.54% | 1 | Aug 27, 2025 | |
| PLRX Pliant Therapeutics | Maintains: Overweight | $17 → $4 | $1.30 | +207.69% | 2 | Aug 8, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Overweight | $78 | $4.23 | +1,746.15% | 1 | Jun 12, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Overweight | $93 → $145 | $52.71 | +175.09% | 2 | Apr 24, 2025 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $51 | $23.87 | +113.66% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $6 | $1.42 | +322.54% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $18.01 | +166.59% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $72.73 | +27.87% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $28.05 | +167.38% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $57.50 | +82.62% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $35.97 | +2.86% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $3.87 | +571.83% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.69 | +3,958.27% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $47.47 | +104.34% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $270 | $191.83 | +40.75% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $21.24 | +257.82% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $5.31 | +370.81% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $13.07 | +129.62% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $9.77 | +22.82% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $6.54 | +1,276.15% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $6.97 | +2,482.50% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $3.38 | +344.44% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $6.38 | +150.98% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $43.05 | +85.83% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $32.85 | +183.11% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $22.94 | +148.47% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $6.37 | +951.81% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $87.54 | -60.02% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $14.17 | +513.97% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $10.17 | +1,620.75% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $66.71 | +7.93% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $7.99 | +525.78% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $1.41 | +2,736.88% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.37 | +4,764.86% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $16.48 | +2,448.54% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $71.71 | +7.38% | 1 | Jul 31, 2020 |
Arcturus Therapeutics Holdings
Nov 11, 2025
Maintains: Overweight
Price Target: $140 → $72
Current: $6.78
Upside: +961.95%
Prothena Corporation
Oct 28, 2025
Maintains: Overweight
Price Target: $15 → $36
Current: $11.30
Upside: +218.58%
Madrigal Pharmaceuticals
Oct 15, 2025
Maintains: Overweight
Price Target: $400 → $540
Current: $591.06
Upside: -8.64%
LB Pharmaceuticals
Oct 6, 2025
Initiates: Overweight
Price Target: $78
Current: $19.36
Upside: +302.89%
Tenax Therapeutics
Sep 8, 2025
Initiates: Overweight
Price Target: $20
Current: $9.34
Upside: +114.13%
Inventiva
Aug 27, 2025
Initiates: Overweight
Price Target: $26
Current: $4.13
Upside: +529.54%
Pliant Therapeutics
Aug 8, 2025
Maintains: Overweight
Price Target: $17 → $4
Current: $1.30
Upside: +207.69%
Tvardi Therapeutics
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $4.23
Upside: +1,746.15%
Soleno Therapeutics
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $52.71
Upside: +175.09%
Edgewise Therapeutics
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $23.87
Upside: +113.66%
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.42
Upside: +322.54%
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $18.01
Upside: +166.59%
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $72.73
Upside: +27.87%
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $28.05
Upside: +167.38%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $57.50
Upside: +82.62%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $35.97
Upside: +2.86%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $3.87
Upside: +571.83%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.69
Upside: +3,958.27%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $47.47
Upside: +104.34%
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $191.83
Upside: +40.75%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $21.24
Upside: +257.82%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $5.31
Upside: +370.81%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $13.07
Upside: +129.62%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $9.77
Upside: +22.82%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $6.54
Upside: +1,276.15%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $6.97
Upside: +2,482.50%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $3.38
Upside: +344.44%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $6.38
Upside: +150.98%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $43.05
Upside: +85.83%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $32.85
Upside: +183.11%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $22.94
Upside: +148.47%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $6.37
Upside: +951.81%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $87.54
Upside: -60.02%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $14.17
Upside: +513.97%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $10.17
Upside: +1,620.75%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $66.71
Upside: +7.93%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $7.99
Upside: +525.78%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $1.41
Upside: +2,736.88%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.37
Upside: +4,764.86%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $16.48
Upside: +2,448.54%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $71.71
Upside: +7.38%